Russell Investments Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $521K | Buy |
45,840
+41,629
| +989% | +$451K | ﹤0.01% | 2483 |
|
|
2025
Q4 | $54.1K | Buy |
4,211
+23
| +0.5% | +$284 | ﹤0.01% | 3271 |
|
|
2025
Q3 | $46.8K | Buy |
4,188
+3,213
| +330% | +$31K | ﹤0.01% | 3315 |
|
|
2025
Q2 | $9.67K | Sell |
975
-10,797
| -92% | -$106K | ﹤0.01% | 3344 |
|
|
2025
Q1 | $111K | Sell |
11,772
-13,207
| -53% | -$139K | ﹤0.01% | 2731 |
|
|
2024
Q4 | $229K | Buy |
24,979
+14,274
| +133% | +$105K | ﹤0.01% | 2506 |
|
|
2024
Q3 | $83.3K | Buy |
10,705
+3,559
| +50% | +$25.7K | ﹤0.01% | 2692 |
|
|
2024
Q2 | $43.2K | Sell |
7,146
-48,180
| -87% | -$297K | ﹤0.01% | 2796 |
|
|
2024
Q1 | $325K | Sell |
55,326
-1,049
| -2% | -$6.23K | ﹤0.01% | 2340 |
|
|
2023
Q4 | $442K | Buy |
56,375
+24,698
| +78% | +$171K | ﹤0.01% | 2258 |
|
|
2023
Q3 | $232K | Buy |
31,677
+2,840
| +10% | +$23.6K | ﹤0.01% | 2462 |
|
|
2023
Q2 | $301K | Buy |
28,837
+439
| +2% | +$4.22K | ﹤0.01% | 2377 |
|
|
2023
Q1 | $294K | Buy |
+28,398
| New | +$363K | ﹤0.01% | 2396 |
|
|
2022
Q2 | – | Sell |
-4,729
| Closed | -$100K | – | 2879 |
|
|
2022
Q1 | $100K | Sell |
4,729
-13,551
| -74% | -$307K | ﹤0.01% | 2563 |
|
|
2021
Q4 | $503K | Sell |
18,280
-6,069
| -25% | -$167K | ﹤0.01% | 2447 |
|
|
2021
Q3 | $631K | Sell |
24,349
-39,746
| -62% | -$1.06M | ﹤0.01% | 2366 |
|
|
2021
Q2 | $1.74M | Buy |
64,095
+15,235
| +31% | +$372K | ﹤0.01% | 2002 |
|
|
2021
Q1 | $1.14M | Buy |
48,860
+241
| +0.5% | +$4.87K | ﹤0.01% | 2195 |
|
|
2020
Q4 | $743K | Buy |
48,619
+12,270
| +34% | +$156K | ﹤0.01% | 2257 |
|
|
2020
Q3 | $438K | Sell |
36,349
-12,638
| -26% | -$120K | ﹤0.01% | 2448 |
|
|
2020
Q2 | $495K | Buy |
48,987
+969
| +2% | +$9.99K | ﹤0.01% | 2385 |
|
|
2020
Q1 | $482K | Sell |
48,018
-62,770
| -57% | -$788K | ﹤0.01% | 2191 |
|
|
2019
Q4 | $1.77M | Buy |
110,788
+91,103
| +463% | +$1.39M | ﹤0.01% | 1810 |
|
|
2019
Q3 | $361K | Buy |
19,685
+5,450
| +38% | +$107K | ﹤0.01% | 2407 |
|
|
2019
Q2 | $281K | Sell |
14,235
-24,337
| -63% | -$496K | ﹤0.01% | 2432 |
|
|
2019
Q1 | $881K | Buy |
38,572
+13,874
| +56% | +$301K | ﹤0.01% | 2136 |
|
|
2018
Q4 | $497K | Buy |
24,698
+23,815
| +2,697% | +$493K | ﹤0.01% | 2325 |
|
|
2018
Q3 | $19K | Sell |
883
-70,264
| -99% | -$1.56M | ﹤0.01% | 2910 |
|
|
2018
Q2 | $1.59M | Sell |
71,147
-34,145
| -32% | -$698K | ﹤0.01% | 1878 |
|
|
2018
Q1 | $1.79M | Sell |
105,292
-13,719
| -12% | -$229K | ﹤0.01% | 1915 |
|
|
2017
Q4 | $1.99M | Buy |
119,011
+10,745
| +10% | +$183K | ﹤0.01% | 1809 |
|
|
2017
Q3 | $1.85M | Sell |
108,266
-18,343
| -14% | -$308K | ﹤0.01% | 1825 |
|
|
2017
Q2 | $2.05M | Sell |
126,609
-189,254
| -60% | -$2.99M | ﹤0.01% | 1719 |
|
|
2017
Q1 | $5.48M | Buy |
315,863
+17,044
| +6% | +$285K | 0.01% | 1166 |
|
|
2016
Q4 | $5.05M | Buy |
+298,819
| New | +$4.98M | 0.01% | 1238 |
|
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Russell Investments Group's ANGO Position: Q1 2026 in Review
Russell Investments Group increased its AngioDynamics (ANGO) stake by 989% in Q1 2026, buying an estimated $451K and bringing the position to 45,840 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.
Russell Investments Group first reported a position in ANGO in Q4 2016 and has held it in 35 quarters since. The position peaked at $5.48M in Q1 2017. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Russell Investments Group held 45,840 shares of AngioDynamics worth $521K as of Q1 2026.
- Russell Investments Group bought 41,629 AngioDynamics shares in Q1 2026, an estimated $451K.
- AngioDynamics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #2483 holding.
- Russell Investments Group first reported a position in AngioDynamics in Q4 2016 and has held it in 35 quarters since.
- Russell Investments Group's AngioDynamics position peaked at $5.48M in Q1 2017.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.